Your browser doesn't support javascript.
loading
Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.
Piersimoni, C; Mustazzolu, A; Iacobino, A; Giannoni, F; Santoro, G; Gherardi, G; Del Giudice, A; Perna, R; Fattorini, L.
Afiliación
  • Piersimoni C; Regional Reference Mycobacteria Laboratory, United Hospitals, Ancona.
  • Mustazzolu A; Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit, Rome.
  • Iacobino A; Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit, Rome.
  • Giannoni F; Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit, Rome.
  • Santoro G; Microbiology and Virology Laboratory, Dei Colli Hospital, Naples, Italy.
  • Gherardi G; Regional Reference Mycobacteria Laboratory, United Hospitals, Ancona.
  • Del Giudice A; Microbiology and Virology Laboratory, Dei Colli Hospital, Naples, Italy.
  • Perna R; Microbiology and Virology Laboratory, Dei Colli Hospital, Naples, Italy.
  • Fattorini L; Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit, Rome.
Int J Tuberc Lung Dis ; 20(12): 1677-1680, 2016 12.
Article en En | MEDLINE | ID: mdl-27931346
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Pirazinamida / Pruebas de Sensibilidad Microbiana / Farmacorresistencia Bacteriana Múltiple / Antituberculosos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2016 Tipo del documento: Article
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Pirazinamida / Pruebas de Sensibilidad Microbiana / Farmacorresistencia Bacteriana Múltiple / Antituberculosos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2016 Tipo del documento: Article